We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
-2.74%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.12B
AUM Growth
-$453M
(-18%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-17.13%
Top 10 Holdings %
Top 10 Hldgs %
34.33%
Holding
91
New
7
Increased
22
Reduced
20
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lantheus
LNTH
|
+$27.3M |
| 2 |
Veeva Systems
VEEV
|
+$16.4M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$14.5M |
| 4 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$14.1M |
| 5 |
TSBX
Turnstone Biologics
TSBX
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$112M |
| 2 |
Penumbra
PEN
|
+$46.5M |
| 3 |
Stryker
SYK
|
+$35.2M |
| 4 |
DVAX
Dynavax Technologies
DVAX
|
+$34.9M |
| 5 |
Universal Health Services
UHS
|
+$26.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 96.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Iovance Biotherapeutics
IOVA
$2.77B
| – | – |
-946,305
| Closed | -$6.66M |
|
77
CALL
iRhythm Holdings
IRTC
$4.21B
| – | – |
-20,000
| Closed | -$2.09M |
|
78
Keros Therapeutics
KROS
$211M
| – | – |
-20,350
| Closed | -$818K |
|
79
Procept Biorobotics
PRCT
$1.14B
| – | – |
-295,544
| Closed | -$10.4M |
|
80
uniQure
QURE
$3.15B
| – | – |
-60,617
| Closed | -$695K |
|
81
Rocket Pharmaceuticals
RCKT
$387M
| – | – |
-238,762
| Closed | -$4.74M |
|
82
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$98.8B
| – | – |
-410,100
| Closed | -$61.4M |
|
|
VERV
83
DELISTED
Verve Therapeutics
VERV
| – | – |
-186,087
| Closed | -$3.49M |
|
84
Waters Corp
WAT
$39.2B
| – | – |
-94,624
| Closed | -$25.2M |
|
85
Zai Lab
ZLAB
$2.36B
| – | – |
-246,706
| Closed | -$6.84M |
|
|
ABCM
86
DELISTED
Abcam PLC
ABCM
| – | – |
-476,430
| Closed | -$11.7M |
|
|
RETA
87
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| – | – |
-145,147
| Closed | -$14.8M |
|
|
HZNP
88
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-1,091,840
| Closed | -$112M |
|
Similar funds
DAM
MAM
DAM
KCM
MIA
YL
SL
PWA
PFM Health Sciences's Q3 2023 Portfolio in Review
As of Q3 2023, PFM Health Sciences held 91 positions worth $2.12B, down 18% from $2.58B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
PFM Health Sciences withdrew a net $364M in Q3 2023, closing 19 positions and reducing 20 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.
Against the trend, PFM Health Sciences opened a new position in Lantheus worth $25.9M.
- PFM Health Sciences's largest Q3 2023 buy was Lantheus: 372,761 shares worth $25.9M.
- PFM Health Sciences added most to Veeva Systems in Q3 2023, an estimated $16.4M increase.
- PFM Health Sciences's biggest Q3 2023 reduction was Penumbra, cutting an estimated $46.5M.
- PFM Health Sciences fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023, selling an estimated $112M.
- PFM Health Sciences's ten largest holdings make up 34% of its $2.12B portfolio in Q3 2023.
- PFM Health Sciences opened 7 new positions and closed 19 in Q3 2023.
- PFM Health Sciences's portfolio value fell 18% quarter-over-quarter to $2.12B.
Based on PFM Health Sciences's 13F filing for Q3 2023, filed 14 Nov 2023.